Elevated levels of adrenomedullin in eutopic endometrium and plasma from women with endometriosis

MR-proADM may be able to serve as a biomarker of endometriosis, but it is unknown whether elevated MR-proADM levels are secondary to the estrogenic and inflammatory properties of endometriosis or an inciting pathogenic factor.